دوره 5، شماره 1 - ( 10-1394 )                   جلد 5 شماره 1 صفحات 44-38 | برگشت به فهرست نسخه ها


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zanganeh S, Roostaei F, Shafiepour M, Mahmoodi M, Khoshdel A, Hajizadeh M. Assessment of serum chemerin level in an Iranian population with metabolic syndrome and healthy individuals in 2016. JOHE. 2016; 5 (1) :38-44
URL: http://johe.rums.ac.ir/article-1-176-fa.html
Assessment of serum chemerin level in an Iranian population with metabolic syndrome and healthy individuals in 2016. . 1394; 5 (1) :44-38

URL: http://johe.rums.ac.ir/article-1-176-fa.html


چکیده:   (6531 مشاهده)

Background: Chemerin is and adipokine produced and secreted by adipose tissue and is associated with functions such as insulin resistance, inflammation, and blood pressure regulation. The purpose of the present study was the determination of serum chemerin level in an Iranian population with metabolic syndrome and its comparison with healthy individuals.

Materials and Methods: The study subjects consisted of 31 individuals with metabolic syndrome and 25 healthy individuals (control group). Serum chemerin level was measured and its relationship with indices of metabolic syndrome, obesity, and insulin resistance was determined. The collected data were analyzed using independent two-sample t-test and the Pearson correlation coefficient in SPSS software.

Results: Serum chemerin level was significantly higher in the metabolic syndrome group compared to the control group (P = 0.009). The mean of the measured indices of BMI (P < 0.001), waist circumference (P < 0.001), systolic blood pressure (P = 0.001), diastolic blood pressure (P < 0.001), insulin resistance (P = 0.001), and triglyceride (P < 0.001) was significantly higher in the metabolic syndrome group compared to the control group. However, HDL level was significantly higher in the control group compared to the metabolic syndrome group (P = 0.007).

Conclusions: Serum chemerin level was higher among patients with metabolic syndrome compared to healthy individuals. Thus, it can be concluded that serum chemerin level measurement can be effective in the diagnosis of this syndrome and determination of appropriate treatment methods.


دریافت: 1395/3/31 | پذیرش: 1395/7/27 | انتشار الکترونیک: 1395/11/6

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2022 CC BY-NC 4.0 | Journal of Occupational Health and Epidemiology

Designed & Developed by : Yektaweb